GlassScriptPhysician profile
Ryan Carl Baker
NPI 1801245956
$7,359.56
in general payments reported to CMS, 2019-2025
49 companies · $1,781 in 2025
The $1,781 reported for 2025 was more than what 77% of Urology providers received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $99.15 · 2020: $46.52 · 2021: $656 · 2022: $1,570 · 2023: $1,380 · 2024: $1,827 · 2025: $1,781.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,954 · Education: $35.06.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,953.58 |
| Education | $35.06 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $792.86 | 2019-2024 | Spaceoar Vue System - 10ml, Lithovue, Rezum Generator |
| Sumitomo Pharma America, INC. | $718.03 | 2023-2025 | Orgovyx, Gemtesa |
| Janssen Biotech, INC. | $657.19 | 2022-2025 | Erleada |
| Procept Biorobotics Corporation | $498.97 | 2023-2025 | Aquabeam System, Aquabeam Robotic System |
| Axonics, INC. | $427.86 | 2021-2024 | Axonics |
| Teleflex LLC | $416.55 | 2021-2024 | Urolift |
| Biotissue Holdings INC. | $360.87 | 2022 | |
| Dendreon Pharmaceuticals LLC | $352.83 | 2021-2025 | Provenge |
| Astellas Pharma US INC | $271.05 | 2021-2025 | Xtandi |
| Coloplast Corp | $165.66 | 2022-2025 | Titan |
| Bayer Healthcare Pharmaceuticals INC. | $159.28 | 2022-2025 | |
| Tempus Ai, INC | $145.07 | 2024-2025 | Xt Cdx |
| Antares Pharma, INC. | $139.50 | 2022-2025 | Xyosted, Tlando, Nocdurna |
| Pfizer INC. | $135.99 | 2022-2025 | |
| Medtronic, INC. | $128.88 | 2023-2025 | Interstim |
Show all 49 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Urogen Pharma, INC. | $126.91 | 2023-2025 | Jelmyto |
| Sun Pharmaceutical Industries INC. | $123.26 | 2023-2024 | Yonsa |
| Urovant Sciences INC | $122.80 | 2021-2022 | |
| Abbvie INC. | $107.74 | 2023-2025 | Botox |
| Novartis Pharmaceuticals Corporation | $103.61 | 2022-2025 | |
| Olympus America INC. | $93.84 | 2023-2025 | Itind System |
| Cook Medical LLC | $91.90 | 2021-2024 | Resonance |
| Endo USA, INC. | $87.17 | 2024-2025 | Xiaflex, Aveed |
| Ferring Pharmaceuticals INC. | $83.72 | 2024-2025 | Adstiladrin |
| Caldera Medical, INC | $83.61 | 2021-2022 | |
| Calyxo, INC. | $79.32 | 2024-2025 | Cvac Aspiration System |
| Baxter Healthcare | $69.05 | 2022-2025 | Floseal |
| Progenics Pharmaceuticals, INC. | $66.33 | 2023-2024 | Pylarify |
| Stryker Corporation | $65.04 | 2023 | |
| Endo Pharmaceuticals INC. | $63.86 | 2021-2024 | Xiaflex, Aveed |
| Astrazeneca Pharmaceuticals LP | $59.25 | 2023-2025 | Imfinzi, Lynparza |
| Innovation Technologies INC | $45.86 | 2023 | Irrisept |
| Telix Pharmaceuticals | $44.63 | 2023-2024 | Illuccix |
| Merck Sharp & Dohme LLC | $44.37 | 2022-2023 | Lynparza, Keytruda |
| Travere Therapeutics, INC. | $42.81 | 2019-2020 | |
| Tolmar, INC. | $38.96 | 2023-2025 | Eligard, Jatenzo |
| Ethicon US, LLC | $34.76 | 2023 | Vistaseal |
| Halozyme INC | $33.16 | 2023 | |
| Caris Mpi, INC. | $31.51 | 2025 | Mi Cancer Seek |
| Myovant Sciences INC. | $30.82 | 2022 | |
| Verity Pharmaceuticals INC. | $30.46 | 2023-2025 | Trelstar |
| Immunitybio, INC. | $28.52 | 2025 | |
| Inspire Medical Systems, INC. | $28.41 | 2025 | Inspire |
| Laborie Medical Technologies Corp. | $27.45 | 2022 | |
| Kerecis Limited | $23.72 | 2024 | Kerecis Omega3 Marigen, Kerecis Omega3 Surgiclose, Kerecis Omega3 Graftguide |
| Karl Storz Endoscopy-America | $21.13 | 2025 | |
| Cumberland Pharmaceuticals, INC. | $19.32 | 2025 | Caldolor |
| Civco Medical Instruments | $18.12 | 2024 | |
| Blue Earth Diagnostics | $17.55 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ryan Baker listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.